Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.32 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1810457 | 0.79 | TRPA1 (0.38) | TRPA1ATMMAPTGABRA1GABRB2 | |
| SCHEMBL9061534 | 0.78 | TRPA1 (0.35) | TRPA1ATMMAPTGABRA1GABRB2 | |
| SCHEMBL2027830 | 0.74 | CA1 (0.41) | ATMTSHR | |
| SCHEMBL10577196 | 0.74 | TRPA1 (0.36) | TRPA1ATMMAPTGABRA1GABRB2 | |
| SCHEMBL3462906 | 0.72 | TRPA1 (0.41) | TRPA1ATMMAPTGABRA1GABRB2 | |
| SCHEMBL2270593 | 0.70 | TRPA1 (0.43) | TRPA1ATMMAPTGABRA1GABRB2 | |
| SCHEMBL628803 | 0.68 | CES1 (0.40) | MAPTTSHR | |
| SCHEMBL1483791 | 0.67 | GABRA1 (0.48) | TRPA1ATMMAPTGABRA1GABRB2 | |
| SCHEMBL472173 | 0.67 | GABRA1 (0.48) | TRPA1ATMMAPTGABRA1GABRB2 | |
| SCHEMBL7312533 | 0.67 | GABRA1 (0.35) | GABRA1GABRB2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107002293-B | Sequencing by synthesis using pulsed readout optics | 艾比斯生物科学公司 | 2020-12-08 | — | — | CN | claimed |
| US-20200123605-A1 | SEQUENCING BY SYNTHESIS USING PULSE READ OPTICS | IBIS BIOSCIENCES, INC. | 2020-04-23 | — | — | US | claimed |
| EP-3194643-B1 | SEQUENCING BY SYNTHESIS USING PULSE READ OPTICS | IBIS BIOSCIENCES INC (US) | 2020-02-19 | — | — | EP | claimed |
| US-10550428-B2 | Sequencing by synthesis using pulse read optics | IBIS BIOSCIENCES, INC. (US) | 2020-02-04 | — | — | US | claimed |
| US-20170247755-A1 | SEQUENCING BY SYNTHESIS USING PULSE READ OPTICS | IBIS BIOSCIENCES, INC. | 2017-08-31 | — | — | US | claimed |
| EP-3194643-A1 | SEQUENCING BY SYNTHESIS USING PULSE READ OPTICS | Ibis Biosciences, Inc. (US) | 2017-07-26 | — | — | EP | claimed |
| WO-2016044391-A1 | SEQUENCING BY SYNTHESIS USING PULSE READ OPTICS | IBIS BIOSCIENCES, INC. (US) | 2016-03-24 | — | — | WO | claimed |
| US-8975216-B2 | Articles having localized molecules disposed thereon and methods of producing same | PACIFIC BIOSCIENCES OF CALIFORNIA (US) | 2015-03-10 | — | — | US | claimed |
| EP-1958955-B1 | Spatially addressable oligonucleotide arrays and method of making the same | CORNELL RES FOUNDATION INC (US) | 2013-09-04 | — | — | EP | claimed |
| US-7879579-B2 | Detection of preferential nucleotide sequences on solid support; generate solid support, incubate with nucleotide sequences, expose to probe, detect signal, presence of signal indicates preferential nucleotide sequences | CORNELL RESEARCH FOUNDATION, INC. (US) | 2011-02-01 | — | — | US | claimed |
| EP-0733213-A1 | PROCESS FOR THE PRODUCTION OF COMBINATORIAL COMPOUND LIBRARIES | Novartis AG (CH) | 1996-09-25 | — | — | EP | claimed |
| US-5510270-A | GENERATING PATTERN OF LIGHT AND DARK AREAS BY SELECTIVELY IRRADIATING SURFACE AREAS; DEPROTECTING; CONTACTING WITH RECEPTOR TO IDENTIFY OLIGONUCLEOTIDE SHOWING COMPLEMENTARITY TO RECEPTOR | AFFYMAX TECHNOLOGIES N.V. | 1996-04-23 | — | — | US | claimed |
| WO-1995016209-A1 | PROCESS FOR THE PRODUCTION OF COMBINATORIAL COMPOUND LIBRARIES | CIBA-GEIGY AG (CH) | 1995-06-15 | — | — | WO | claimed |
| US-5424186-A | Biosynthesis of oligonucleotides on solid substrate by irradiation of predefined segments to remove blocking agents; then coupling with nucleotide | AFFYMAX TECHNOLOGIES N.V. (AN) | 1995-06-13 | — | — | US | claimed |
| US-5412087-A | Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces | AFFYMAX TECHNOLOGIES N.V. (AN) | 1995-05-02 | — | — | US | claimed |
| EP-0619321-A1 | Very large scale immobilized peptide synthesis | AFFYMAX TECHNOLOGIES N.V. (AN) | 1994-10-12 | — | — | EP | claimed |
| EP-0476014-B1 | VERY LARGE SCALE IMMOBILIZED POLYMER SYNTHESIS | AFFYMAX TECH NV (AN) | 1994-08-31 | — | — | EP | claimed |
| WO-1993022680-A1 | SPATIALLY-ADDRESSABLE IMMOBILIZATION OF OLIGONUCLEOTIDES AND OTHER BIOLOGICAL POLYMERS ON SURFACES | AFFYMAX TECHNOLOGIES N.V. (AN) | 1993-11-11 | — | — | WO | claimed |
| EP-0476014-A1 | VERY LARGE SCALE IMMOBILIZED POLYMER SYNTHESIS. | AFFYMAX TECH NV (NL) | 1992-03-25 | — | — | EP | claimed |
| WO-1990015070-A1 | VERY LARGE SCALE IMMOBILIZED PEPTIDE SYNTHESIS | AFFYMAX TECHNOLOGIES N.V. (AN) | 1990-12-13 | — | — | WO | claimed |